Here you will find the biographies of the former CEO's.
Friedrich Bayer (1825–1880)
He sowed the seed for the future Bayer AG by entering "Friedrich Bayer et. Compagnie" into the commercial register on August 1, 1863.
Johann Friedrich Westkott (1821–1876)
The master dyer founded the company together with salesman Friedrich Bayer.
Carl Duisberg (1861–1935)
One of the central figures in Bayer’s history. Duisberg’s work was crucial to Bayer’s progress toward becoming a global group of companies.
Felix Hoffmann (1868–1946)
The chemist invented the "drug of the century", Aspirin™.
Gerhard Domagk (1895–1964)
The scientist was awarded the Nobel Prize in 1939.
Otto Bayer (1902–1982)
Otto Bayer’s greatest achievements included the invention of polyurethane chemistry.
Ulrich Haberland (1900–1961)
The first Chairman of the Board of Management following World War II played the leading role in Bayer’s re-emergence in the 1950s.
Kurt Hansen (1910–2002)
Management Board Chairman from 1961 to 1974.
He played an outstanding part in the restructuring and international expansion of the Bayer Group.
Herbert Grünewald (1921–2002)
Management Board Chairman from 1974 to 1984.
A pioneer with respect to industry's ecological and social responsibility.
Hermann Josef Strenger (*1928)
As Management Board Chairman between 1984 and 1992, he strengthened the company’s divisional and financial structures.
Manfred Schneider (*1938)
His tenure as Management Board Chairman from 1992 to 2002 saw such important milestones as the reacquisition of Bayer’s trademark rights in the United States, the listing of Bayer AG’s shares on the New York Stock Exchange and the preparation of Bayer’s reorganization into the current holding structure.
Werner Wenning (*1946)
As Chairman of the Board of Management from 2002 to 2010, Wenning gave the Bayer Group a completely new structure comprising a strategic holding company, subgroups and service companies.Milestones during this period included the acquisitions of Schering AG, Berlin, Germany, and the consumer health business of Roche, the integration of Aventis CropScience and the spin-off of Lanxess.
Dr. Marijn Dekkers (*1957)
Between 2010 and 2016, Marijn Dekkers has transformed Bayer into an innovative Life Science company in his role as the Chairman of the Board of Management. This involved measures including the acquisition of the consumer care business of Merck & Co., Inc., the carve-out of the MaterialScience subgroup and its stock market flotation as Covestro, and the adjustment of the company’s organizational structure.